Evidence map›Paper›PMID 30870417›Full record

ArticlePLoS neglected tropical diseases2019

Molecular and antigenic characterization of Trypanosoma cruzi TolT proteins.

Maite Lobo, Virginia Balouz, Luciano Melli, Giannina Carlevaro, María E Cortina, María de Los Milagros Cámara, Gaspar E Cánepa, Santiago J Carmona, Jaime Altcheh, Oscar Campetella and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Theracurmin Modulates Cardiac Inflammation in Experimental Model ofTropical medicine and infectious disease · 2023
    Article
  4. Article
  5. Review
  6. Molecular Characterization of Tc964, A Novel Antigenic Protein fromInternational journal of molecular sciences · 2020
    Article
  7. Frontiers in cellular and infection microbiology · 2020
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Maite LoboInstituto de Investigaciones Biotecnológicas "Dr Rodolfo Ugalde" (IIB-INTECh, Universidad Nacional de San Martín and CONICET), Buenos Aires, Argentina.
Virginia BalouzInstituto de Investigaciones Biotecnológicas "Dr Rodolfo Ugalde" (IIB-INTECh, Universidad Nacional de San Martín and CONICET), Buenos Aires, Argentina.
Luciano MelliInstituto de Investigaciones Biotecnológicas "Dr Rodolfo Ugalde" (IIB-INTECh, Universidad Nacional de San Martín and CONICET), Buenos Aires, Argentina.
Giannina CarlevaroInstituto de Investigaciones Biotecnológicas "Dr Rodolfo Ugalde" (IIB-INTECh, Universidad Nacional de San Martín and CONICET), Buenos Aires, Argentina.
María E CortinaInstituto de Investigaciones Biotecnológicas "Dr Rodolfo Ugalde" (IIB-INTECh, Universidad Nacional de San Martín and CONICET), Buenos Aires, Argentina.
María de Los Milagros CámaraInstituto de Investigaciones Biotecnológicas "Dr Rodolfo Ugalde" (IIB-INTECh, Universidad Nacional de San Martín and CONICET), Buenos Aires, Argentina.
Gaspar E CánepaInstituto de Investigaciones Biotecnológicas "Dr Rodolfo Ugalde" (IIB-INTECh, Universidad Nacional de San Martín and CONICET), Buenos Aires, Argentina.
Santiago J CarmonaInstituto de Investigaciones Biotecnológicas "Dr Rodolfo Ugalde" (IIB-INTECh, Universidad Nacional de San Martín and CONICET), Buenos Aires, Argentina.
Jaime AltchehServicio de Parasitología-Chagas, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina.
Oscar CampetellaInstituto de Investigaciones Biotecnológicas "Dr Rodolfo Ugalde" (IIB-INTECh, Universidad Nacional de San Martín and CONICET), Buenos Aires, Argentina.
Andrés E CiocchiniInstituto de Investigaciones Biotecnológicas "Dr Rodolfo Ugalde" (IIB-INTECh, Universidad Nacional de San Martín and CONICET), Buenos Aires, Argentina.
Fernán AgüeroInstituto de Investigaciones Biotecnológicas "Dr Rodolfo Ugalde" (IIB-INTECh, Universidad Nacional de San Martín and CONICET), Buenos Aires, Argentina.
Juan MucciInstituto de Investigaciones Biotecnológicas "Dr Rodolfo Ugalde" (IIB-INTECh, Universidad Nacional de San Martín and CONICET), Buenos Aires, Argentina.
Carlos A BuscagliaInstituto de Investigaciones Biotecnológicas "Dr Rodolfo Ugalde" (IIB-INTECh, Universidad Nacional de San Martín and CONICET), Buenos Aires, Argentina.ORCID 0000-0001-6466-4138
Consejo Nacional de Investigaciones Científicas y Técnicas · ARHospital General de Niños Ricardo Gutierrez · AR

Funding

Role in pathogenesis and parasite cell biology of the trans-sialidase from Trypanosoma cruzi, the agent of Chagas DiseaseR01AI104531 · NIAID · INSTITUTE/RESEARCH/BIOTECHNOLOGY FDN · PI CAMPETELLA, OSCAR EDUARDO · 2014 to 2023
$1.3M
HIGH-THROUGHPUT EPITOPE DISCOVERY: USE OF NEXT-GENERATION PEPTIDE CHIPS FOR FAST IDENTIFICATION AND FINE MAPPING OF DIAGNOSTIC AND PROGNOSTIC MARKERS FOR CHAGAS DISEASER01AI123070 · NIAID · INSTITUTE/RESEARCH/BIOTECHNOLOGY FDN · PI AGUERO, FERNAN GONZALO · 2016 to 2020
$611k
NIAID NIH HHS R01 AI104531NIAID NIH HHS R01 AI123070
6 · The paper itself

Abstract

backgroundTolT was originally described as a Trypanosoma cruzi molecule that accumulated on the trypomastigote flagellum bearing similarity to bacterial TolA colicins receptors. Preliminary biochemical studies indicated that TolT resolved in SDS-PAGE as ~3-5 different bands with sizes between 34 and 45 kDa, and that this heterogeneity could be ascribed to differences in polypeptide glycosylation. However, the recurrent identification of TolT-deduced peptides, and variations thereof, in trypomastigote proteomic surveys suggested an intrinsic TolT complexity, and prompted us to undertake a thorough reassessment of this antigen. METHODS/PRINCIPLE

findingsGenome mining exercises showed that TolT constitutes a larger-than-expected family of genes, with at least 12 polymorphic members in the T. cruzi CL Brener reference strain and homologs in different trypanosomes. According to structural features, TolT deduced proteins could be split into three robust groups, termed TolT-A, TolT-B, and TolT-C, all of them showing marginal sequence similarity to bacterial TolA proteins and canonical signatures of surface localization/membrane association, most of which were herein experimentally validated. Further biochemical and microscopy-based characterizations indicated that this grouping may have a functional correlate, as TolT-A, TolT-B and TolT-C molecules showed differences in their expression profile, sub-cellular distribution, post-translational modification(s) and antigenic structure. We finally used a recently developed fluorescence magnetic beads immunoassay to validate a recombinant protein spanning the central and mature region of a TolT-B deduced molecule for Chagas disease serodiagnosis. CONCLUSION/SIGNIFICANCE: This study unveiled an unexpected genetic and biochemical complexity within the TolT family, which could be exploited for the development of novel T. cruzi biomarkers with diagnostic/therapeutic applications.

Indexed as

Polymorphism, GeneticAntigens, ProtozoanComputational BiologyGlycosylationImmunoassayMembrane ProteinsProtozoan ProteinsAntigens, ProtozoanMembrane ProteinsProtozoan ProteinsTolT protein, Trypanosoma cruzi

Identifiers

PMID30870417
PMCPMC6435186
OpenAlexW2921454621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.